Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Lancet Child Adolesc Health. 2018 Feb;2(2):112–120. doi: 10.1016/S2352-4642(17)30181-5

Table 2.

Day 3 AKI, Demographics and Outcomes

Variable No AKIS
N=1222 (76.8)
AKIS
N=368 (23.1)
P Value

Male 683 (55.9) 199 (54.1) 0.54

Age in months 49.1 (16.3, 127.9) 75.5 (17.9, 165.7) 0.002

BSA m2 0.67 (0.46, 1.18) 0.84 (0.47, 1.36) 0.005

Diagnosis Group*
Shock 343 (28.1) 129 (35.1) 0.01
CV 70 (5.7) 29 (7.9) 0.13
Respiratory 581 (47.5) 167 (45.4) 0.47
Trauma 237 (19.4) 90 (24.5) 0.04
CNS 263 (21.5) 64 (17.4) 0.09
Pain Management or Sedation 41 (3.4) 12 (3.3) 0.93

History of Transplantation 62 (5.1) 50 (13.6) <0.001

Severity of Illness Score
PRISM-3 5 (3, 8) 7 (3, 12) 0.03
PIM-2 3 (1, 4) 3 (1, 5) 0.09
PELOD 11 (1, 12) 11 (1, 12) 0.52

RA+ 165 (13.5) 121 (32.9) <0.001

Day 0 KDIGO AKI
No AKI 1040 (85.1) 248 (67.4) <0.001
Stage 1 140 (11.5) 34 (9.2) 0.23
Stage 2 55 (4.5) 37 (10.0) <0.001
Stage 3 23 (1.9) 49 (13.3) <0.001
All-stage AKI 218 (17.8) 120 (32.6) <0.001
Severe AKI 78 (6.4) 86 (23.4) <0.001

Ventricular Assist Device 3 (0.2) 1 (0.3) 0.93

ECMO 14 (1.1) 9 (2.4) 0.07

Renal Replacement Therapy 18 (1.5) 40 (10.9) <0.001

MV Duration 1 (0, 6) 1 (0, 5) 0.57

ICU LOS 5 (4, 9) 4 (3, 7.8) <0.001

Mortality 53 (4.3) 28 (7.6) 0.01

Categorical Variables expressed as n (% of cohort)

Continuous Variables expressed as medians with interquartile ranges

Day 3 AKI = KDIGO ≥ Stage 2

*

More than one diagnosis group is possible

N = population, BSA = body surface area, IQR = interquartile range, CV = cardiovascular, CNS = central nervous system, PRISM-3 = Pediatric Risk of Mortality 3, PIM-2 =Pediatric Index of Mortality 2, PELOD = Pediatric Logistic Organ Dysfunction, KDIGO - Kidney Diseases Improving Global Outcomes, AKI = acute kidney injury, RA+ = renal angina positive, ICU = intensive care unit, ECMO = extracorporeal membrane oxygenation, MV = mechanical ventilation, LOS = length of stay